Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

American Journal of Medicine

Volumn 100, Issue 6 A, 1996, Pages 83S-89S

  Ramphal, Reuben ^a   Gucalp, Rasim ^b   Rotstein, Coleman ^c   Cimino, Michael ^c   Oblon, David ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTAZIDIME; GENTAMICIN; PIPERACILLIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; VANCOMYCIN;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; ARTICLE; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY; SUPERINFECTION;

ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; FEMALE; FEVER; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PENICILLINS; PIPERACILLIN; PROSPECTIVE STUDIES; SUPERINFECTION; VANCOMYCIN;

EID: 0030600064     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)00113-1     Document Type: Conference Paper

References (17)

1. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis. 1990;161:381-396.
2. EORTC and National Cancer Institute of Canada. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis. 1991;163:951-958.
3. Johnson MP, Ramphal R. β-Lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis. 1990;162:981-983.
4. Liang R, Yung R, Chiu E, et al. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients. Antimicrob Agents Chemother. 1990;34:1336-1341.
5. Jacoby GA, Medeiros AA. Minireview: more extended-spectrum β-lactamases. Antimicrob Agents Chemotner. 1991;35:1697-1704.
6. Kessler RE. Data on file, Bristol-Myers Squibb. 1988.
7. Bodey GP, Ho DH, LeBlanc B. In vitro studies of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985;27:265-269.
8. Pechère JC, Vladoianu R. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model. J Antimicrob Chemother. 1992;29:563-573.
9. Sirot D, Chanal C, Labia R, Sirot J. Susceptibility of new β-lactams to the expanded-spectrum β-lactamase CTX-1. Infection. 1989;17:28-30.
10. Jacoby GA, Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother. 1990;34:858-862.
11. Eggimann P, Glauser MP, Aoun M, Meunier F, Calandra T. Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients. J Antimicrob Chemother. 1993;32:151-163.
12. Pizzo PA, Hathorn JW, Hiemenz J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med. 1986;315:552-558.
13. The EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med. 1987;317:1692-1698.
14. The Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J Infect Dis. 1990;161:397-401.
15. Ramphal R, Bolger M, Oblon DJ, et al. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study. Antimicrob Agents Chemother. 1992;36:1062-1067.
16. Rubin M, Hathorn J, Marshall D, Gress J, Steinberg SM, Pizzo PA. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med. 1988;108:30-35.
17. Rolston KVI, Berkey P, Bodey GP, et al. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Arch Intern Med. 1992;152:283-291.